The insider buys are a modest bullish signal reinforcing the post-earnings positive read. Monitor for further C-suite open-market purchases, if more top executives buy in the next 2-4 weeks, it would confirm strong conviction behind the raised guidance.
ELAN drugs
ELAN drug pipeline →How the stock moved after the report
BULLISH VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Aug 19 $24.50entry
- T+1 · 3mo ago −3.84%α −3.00% · $23.56
- T+5 · 3mo ago +2.37%α +2.75% · $25.08
- T+20 · 2mo ago −7.18%α −6.34% · $22.74
- T+60 · 5d ago +8.16%α +9.72% · $26.50
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Two ELAN insiders, Director Michael J. Harrington and General Counsel Shiv O'Neill, made open-market purchases totaling $203K over a one-week window ending August 18, 2026, following the company's Q2 2026 beat-and-raise earnings report. Harrington bought 5,000 shares at $21.82 on August 12, and O'Neill bought 3,998 shares at $23.58 on August 18. The buying supports the bullish earnings narrative but is small relative to Elanco's $11.8B market cap ($203K = ~0.002%), making it a modest confidence signal rather than a market-moving event. The cluster of buys, especially after a positive earnings catalyst, is directionally consistent with management's confidence in the raised guidance.
Key Financial Metrics
Key Facts
- Insider cluster of two open-market purchases totaling $203,273, 0.002% of market cap.
- Director Michael J. Harrington bought 5,000 shares at $21.82 ($109,100) on August 12, 2026.
- GC & Corp Sec Shiv O'Neill bought 3,998 shares at $23.58 ($94,273) on August 18, 2026.
- Buys come 7-14 days after a bullish Q2 2026 earnings beat (adj. EPS $0.34 vs. $0.27 consensus) and raised FY guidance.
- No 10b5-1 pattern evident, timing and sizes suggest opportunistic conviction buying.
Financial Impact
Insider purchases total ~0.002% of $11.8B market cap, economically trivial but directionally positive as a signal.
Risk Factors
- Dollar amount is negligible relative to market cap, should not be overweighted.
- Single C-suite buyer (GC, not CEO/CFO) limits signal strength.
- ELAN is highly followed (91% analyst bullish), upside may be priced in already.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-ELAN-1787121145985 |
Track record
19 reports on ELAN
4 of 5 bullish or bearish reports moved the stock their way by T+60. Best: +15.03% at T+5 after the May 19, 2026 report. 8 of 9 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $26.68 Now $26.41 −1.01% settles Feb 12
- Nov 12, 20264d ago SC 13G/A Neutral 2/10 Entry $26.78 Now $26.41 −1.38% settles Feb 11
- Nov 6, 202610d ago 8-K Bullish 6/10 Entry $25.74 Now $26.41 +2.60% settles Feb 4
- Nov 5, 202611d ago SC 13G/A Neutral 3/10 Entry $23.68 Now $26.41 +11.53% settles Feb 3
- Nov 3, 202613d ago 3 Neutral 1/10 Entry $25.31 Now $26.41 +4.35% settles Feb 2
- Oct 14, 20264w ago Institutional Cluster Bullish 4/10 Entry $23.54 Now $26.41 +12.19% settles Jan 12
- Sep 11, 20269w ago Press Release Neutral 1/10 Entry $23.17 Now $26.41 +13.98% settles Dec 7
- Aug 21, 202612w ago Insider Cluster Bullish 6/10 Entry $24.42 Now $26.41 +8.15% settles Nov 17
- Aug 21, 202612w ago Insider Cluster Bullish 4/10 Entry $24.42 Now $26.41 +8.15% settles Nov 17
- Aug 18, 202612w ago Insider Cluster Bullish 4/10 Viewing Entry $24.50 to $26.50 Now $26.41 +7.80% ▲ +8.16% +9.72% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers